Checkpoint Inhibitors In Hematologic Malignancies

Andre Goy, MD, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical Center, discusses Checkpoint Inhibitors In Hematologic Malignancies. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com